Draft. Pending scientific and legal review. Not medical advice.

Difference between exome and genome

The exome mainly sequences protein-coding DNA regions. The whole genome covers a much larger share of DNA, including non-coding regions. Neither detects every possible genetic cause. The choice depends on clinical suspicion and is made by the professional.

Exome (WES)

A clinical exome focuses on coding DNA, where many variants linked to known Mendelian diseases are found. It is often the first step in broad sequencing when the clinical question is open but the phenotype suggests a genetic cause.

It does not cover all hard-to-sequence regions equally, nor every structural variant.

Genome (WGS)

Whole-genome sequencing is broader. It may improve detection of certain variants in non-coding regions and of some structural changes, depending on method and bioinformatics. It involves more data, more interpretive complexity and often a more detailed consent frame for unsolicited findings.

Unsolicited findings

Broad sequencing can generate unsolicited findings. Which categories are returned, and whether the person wants to know them, is recorded in consent before the test. ACMG recommendations and ESHG guidance provide a reference frame; concrete application belongs to the laboratory and clinician.

In the Xenomium catalogue, exome and genome sit in the NGS sequencing line.

Sources

Request through your healthcare professional